<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28584287</article-id>
<article-id pub-id-type="pmc">5863913</article-id>
<article-id pub-id-type="doi">10.1038/mp.2017.124</article-id>
<article-id pub-id-type="manuscript">NIHMS948282</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2α</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kabir</surname>
<given-names>ZD</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Che</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fischer</surname>
<given-names>DK</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rice</surname>
<given-names>RC</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rizzo</surname>
<given-names>BK</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Byrne</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glass</surname>
<given-names>MJ</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Marco Garcia</surname>
<given-names>NV</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rajadhyaksha</surname>
<given-names>AM</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Pediatric Neurology, Pediatrics, Weill Cornell Medicine, New York, NY, USA</aff>
<aff id="A2">
<label>2</label>Weill Cornell Autism Research Program, Weill Cornell Medicine, New York, NY, USA</aff>
<aff id="A3">
<label>3</label>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence: Dr AM Rajadhyaksha, Pediatric Neurology, Pediatrics, Weill Cornell Medicine, 1300 York Avenue, Box 91, New York, NY 10065, USA. <email>amr2011@med.cornell.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>CONFLICT OF INTEREST</bold>
</p>
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>22</volume>
<issue>8</issue>
<fpage>1096</fpage>
<lpage>1109</lpage>
<!--elocation-id from pubmed: 10.1038/mp.2017.124-->
<abstract>
<p id="P1"><italic>CACNA1C</italic>, encoding the Ca<sub>v</sub>1.2 subunit of L-type Ca<sup>2+</sup> channels, has emerged as one of the most prominent and highly replicable susceptibility genes for several neuropsychiatric disorders. Ca<sub>v</sub>1.2 channels play a crucial role in calcium-mediated processes involved in brain development and neuronal function. Within the <italic>CACNA1C</italic> gene, disease-associated single-nucleotide polymorphisms have been associated with impaired social and cognitive processing and altered prefrontal cortical (PFC) structure and activity. These findings suggest that aberrant Ca<sub>v</sub>1.2 signaling may contribute to neuropsychiatric-related disease symptoms via impaired PFC function. Here, we show that mice harboring loss of <italic>cacna1c</italic> in excitatory glutamatergic neurons of the forebrain (fbKO) that we have previously reported to exhibit anxiety-like behavior, displayed a social behavioral deficit and impaired learning and memory. Furthermore, focal knockdown of <italic>cacna1c</italic> in the adult PFC recapitulated the social deficit and elevated anxiety-like behavior, but not the deficits in learning and memory. Electrophysiological and molecular studies in the PFC of <italic>cacna1c</italic> fbKO mice revealed higher E/I ratio in layer 5 pyramidal neurons and lower general protein synthesis. This was concurrent with reduced activity of mTORC1 and its downstream mRNA translation initiation factors eIF4B and 4EBP1, as well as elevated phosphorylation of eIF2α, an inhibitor of mRNA translation. Remarkably, systemic treatment with ISRIB, a small molecule inhibitor that suppresses the effects of phosphorylated eIF2α on mRNA translation, was sufficient to reverse the social deficit and elevated anxiety-like behavior in adult <italic>cacna1c</italic> fbKO mice. ISRIB additionally normalized the lower protein synthesis and higher E/I ratio in the PFC. Thus this study identifies a novel Ca<sub>v</sub>1.2 mechanism in neuropsychiatric-related endophenotypes and a potential future therapeutic target to explore.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>